Ten weeks after TAC, AMPKα2-/- mice developed similar hypertrophy (Fig 7A) but exhibited worsening of cardiac function (Table 1) as shown by greater reduction in ejection fraction as compared with WT mice (Fig 7B). This evidence concerns the gene PRKAA2 and persistent truncus arteriosus.